Navigation Links
Obesity and Diabetes Are Increasing in Cats

ST. JOSEPH, Mo., Nov. 10, 2010 /PRNewswire/ -- Diabetes isn’t just a human disease. This November – American Diabetes Month® – pet owners should know that the feline members of their families could suffer from the condition, too.

Type 2 diabetes is the most common form in the United States and occurs in both cats and people. Feline diabetes, a treatable and manageable disease on the rise, affects approximately one in 200 cats nationwide.

"Similar to humans, obesity predisposes cats to diabetes, making diet a major factor in maintaining a cat’s health," says Ruth MacPete, DVM, a San Diego based veterinarian. "Feline diabetes, like most diseases, is easier to treat the earlier it is diagnosed."

Early warning signs include:

  • Increased thirst
  • Sudden increase in appetite
  • Sudden weight loss (despite an increase in appetite)
  • Increased urination
  • Increased lethargy

Most cats with feline diabetes may still maintain an active and healthy lifestyle. Along with appropriate diet and exercise, veterinarians often recommend insulin injections.

"Veterinarians are fortunate enough to now have PROZINC® insulin, the first and only FDA approved long-acting insulin for cats, available to help them effectively regulate their feline diabetic patients,” says MacPete. As with all insulins, cats should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with PROZINC. Routine monitoring of clinical signs and blood parameters, such as glucose and fructosamine, is essential to maintain a regulated cat.

While November is American Diabetes Month®, pet owners should monitor their cats for symptoms of feline diabetes year-round. The American Association of Feline Practitioners recommends that a veterinarian examine cats at least once a year and twice annually if they are over the age of seven.

For more information about feline diabetes, please visit

For more information about PROZINC, please visit

About Boehringer Ingelheim

Boehringer Ingelheim Vetmedica, Inc. (St. Joseph, Mo.), is a subsidiary of Boehringer Ingelheim Corporation based in Ridgefield, Conn., and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 138 affiliates in 47 countries and approximately 41,300 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2008, Boehringer Ingelheim posted net sales of US $17 billion (11.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development. For more information, please visit:

SOURCE Boehringer Ingelheim Vetmedica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America
2. Results of Two New Clinical Studies Show Promise of Emerging Mobile Health Technology to Combat Obesity Epidemic
3. A Majority of Surveyed PCPs and Endocrinologists Indicate that they will Prescribe Contrave, Lorqess and Qnexa if these Therapies are Approved for Obesity
4. Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia
5. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
6. SIRIUS XMs Doctor Radios The Deans List To Focus On Link Between Early Antibiotic Use In Children And Obesity
7. FierceBiotech Names Obesity Company Gelesis to Fierce 15 List of Top Emerging Biotech Companies
8. Obesity Expert to Speak to FDA in Support of Treatment Options for Obese Patients
9. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
10. Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity From Its Broad Metabolic Disease Franchise at ADA Scientific Sessions
11. Zydus Novel Orally Administered GLP-1 Agonist - ZYOG1 to treat Diabetes and Obesity Enters Phase I Clinical Trial
Post Your Comments:
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):